Capital Investment Counsel, LLC

Position in ABBV — AbbVie Inc.

CIK 2033609 DENVER, CO

Position in ABBV

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$12,427,996

+$1,822,314 QoQ

Shares Held

49,388

+1.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

3.12%

of 13F equity value

Holder Rank

#807

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Capital Investment Counsel, LLC holds $30,068,995 across 6 Drug Manufacturers - General names. ABBV ranks #1 (41.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	49,388	$12,427,996
2	AMGN	Amgen Inc	20,071	$7,268,110
3	GILD	Gilead Sciences, Inc.	49,570	$6,262,673
4	LLY	ELI LILLY & Co	2,935	$3,520,327
5	JNJ	Johnson & Johnson	1,290	$327,621
6	MRK	Merck & Co., Inc.	2,041	$262,268

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,427,996	49,388	+1.3%	Shares	Sole	2026-07-15
2026-03-31	$10,605,682	48,764	+1.6%	Shares	Sole	2026-04-23
2025-12-31	$10,969,804	48,010	+0.4%	Shares	Sole	2026-02-02
2025-09-30	$11,076,642	47,839	-4.9%	Shares	Sole	2025-11-06
2025-06-30	$9,340,584	50,321	-2.3%	Shares	Sole	2025-08-01
2025-03-31	$10,796,565	51,530	-2.2%	Shares	Sole	2025-05-15
2024-12-31	$9,364,790	52,700	+0.4%	Shares	Sole	2025-01-23
2024-09-30	$10,361,973	52,471	+1.7%	Shares	Sole	2024-11-12
2024-06-30	$8,850,775	51,602	+4.8%	Shares	Sole	2024-08-14
2024-03-31	$8,969,517	49,256	+55.4%	Shares	Sole	2024-08-14
2023-12-31	$4,912,703	31,701	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.